Fecal Microbiota Transplantation Can Alleviate Gastrointestinal Transit in Rats with High-Fat Diet-Induced Obesity via Regulation of Serotonin Biosynthesis

Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome

(2017) Julien Tap et al.   GASTROENTEROLOGY

Involvement of gut microbiota in the association between gastrointestinal motility and 5-HT expression/M2 macrophage abundance in the gastrointestinal tract

(2017) Mo Yang et al.   Molecular Medicine Reports

Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity

(2017) Tanusree Sen et al.   PHYSIOLOGY & BEHAVIOR

Efficacy and Safety of Serotonin Receptor Ligands in the Treatment of Irritable Bowel Syndrome: A Review

(2017) Agata Binienda et al.   CURRENT DRUG TARGETS

Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease

(2016) Yoosoo Chang et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Metabolically healthy obesity across the life course: epidemiology, determinants, and implications

(2016) Catherine M. Phillips   Annals of the New York Academy of Sciences

Fundamentals of Neurogastroenterology: Physiology/Motility – Sensation

(2016) Guy Boeckxstaens et al.   GASTROENTEROLOGY

The Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous System

(2016) Yuuki Obata et al.   GASTROENTEROLOGY

Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis

(2015) Jessica M. Yano et al.   CELL

Sex-related differences in small intestinal transit and serotonin dynamics in high-fat-diet-induced obesity in mice

(2015) Marion France et al.   EXPERIMENTAL PHYSIOLOGY

Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells

(2015) Christopher S. Reigstad et al.   FASEB JOURNAL

The effects of serotonin on the electrophysiological properties of atrioventricular node during an experimental atrial fibrillation

(2015) Shima Changizi et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis

(2014) Justin D Crane et al.   NATURE MEDICINE

Effects of gastrointestinal motility on obesity

(2014) Xiao-Yi Fu et al.   Nutrition & Metabolism

Combination of intrauterine growth restriction and a high-fat diet impairs cholesterol elimination in rats

(2014) Erin K. Zinkhan et al.   PEDIATRIC RESEARCH

Lactobacillus casei reduces susceptibility to type 2 diabetes via microbiota-mediated body chloride ion influx

(2014) Yong Zhang et al.   Scientific Reports

Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice

(2013) Yvonne Ritze et al.   BMC GASTROENTEROLOGY

PP053-SUN EFFECT OF TRYPTOPHAN SUPPLEMENTATION ON DIET-INDUCED NON-ALCOHOLIC FATTY LIVER DISEASE IN MICE

(2013) Y. Ritze et al.   CLINICAL NUTRITION

Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants

(2013)   LANCET

Impairment of reproductive function in a male rat model of non-alcoholic fatty liver disease and beneficial effect of N-3 fatty acid supplementation

(2013) Yan Li et al.   TOXICOLOGY LETTERS

Dual probiotic strains suppress high fructose-induced metabolic syndrome

(2013) Do-Young Park   WORLD JOURNAL OF GASTROENTEROLOGY

5-Hydroxytryptamine (serotonin) in the gastrointestinal tract

(2013) Michael D. Gershon   Current Opinion in Endocrinology Diabetes and Obesity

The Receptor TGR5 Mediates the Prokinetic Actions of Intestinal Bile Acids and Is Required for Normal Defecation in Mice

(2012) Farzad Alemi et al.   GASTROENTEROLOGY

Carcinogenicity of deoxycholate, a secondary bile acid

(2011) Carol Bernstein et al.   ARCHIVES OF TOXICOLOGY

An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota

(2011) Ian B Jeffery et al.   GUT

A high-fat diet temporarily accelerates gastrointestinal transit and reduces satiety in men

(2011) Miriam E. Clegg et al.   INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION

Serotonin Receptor Type 3 Antagonists Improve Obesity-Associated Fatty Liver Disease in Mice

(2011) S. Haub et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Gastrointestinal symptoms and obesity: a meta-analysis

(2011) G. D. Eslick   Obesity Reviews

Small Intestinal Clustered Contractions and Bacterial Overgrowth: A Frequent Finding in Obese Patients

(2010) Ana María Madrid et al.   DIGESTIVE DISEASES AND SCIENCES

Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome

(2010) J. Bernadette Moore   PROCEEDINGS OF THE NUTRITION SOCIETY

Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice

(2009) Synia Haub et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY